We believe that all Australians should be able to benefit from high-quality, locally-produced prescription medicines that have been created to the highest possible standard.
We know that no two patients are alike, and we are committed to developing unique strains and exclusive cannabinoid products to meet individual needs.
Often referred to as ‘medical marijuana’ or ‘medical cannabis’, medicinal cannabis is a term used to describe the use of the cannabis plant and its derivative extracts for therapeutic benefits. The term ‘cannabinoid’ refers to compounds found in the cannabis plant, including tetrahydrocannabinol (THC) and cannabidiol (CBD) – which can provide medicinal relief.
In the past 20 years, there has been increasing international focus on the medical potential of cannabis. Today, substantial evidence now exists demonstrating the efficacy of certain forms of cannabis as a treatment option for various medical conditions.
Current potential uses of cannabis (as adjunctive therapy or second line treatment) include1,2:
However, the therapeutic use of cannabis is under investigation for many, many more conditions.
Following the lead of countries like Canada and Israel, Australia legalised the cultivation of medicinal cannabis in early 2016. This legislation change, welcomed by thousands of patients with chronic and painful conditions, will advance scientific research into the therapeutic benefits of cannabinoid-based medical treatments – and will build the foundations of a commercial medical cannabis industry through a national licensing and permit scheme.
Medicinal cannabis can only be prescribed by a registered medical practitioner.
Before prescribing medicinal cannabis, the doctor will assess each patient to decide if the treatment is appropriate for their condition and individual circumstances.
For specific information for doctors on how to access medicinal cannabis products in Australia, please read this resource created by the Therapeutics Goods Administration.
At ANTG, we are dedicated to discovering and delivering the future of natural health and wellbeing.
Our team of master growers and plant scientists have years of experience, producing consistent high-volume yields of exceptional-quality medicinal cannabis. Our deep-rooted history in hemp cultivation means we understand the ideal plant harvest windows through cannabinoid profiling.
Our Australian home base uses best-in-class cultivation, extraction and laboratory processes – which not only guarantees superior quality and medicinal benefit, but also makes the process as clean and environmentally friendly as possible.
Our mastery in cannabis means we have the skill and experience to produce medicinal cannabis with a variable ratio of CBD and THC – tailoring treatments to the patient.
The ratio of CBD and THC can be varied to create three strains of cannabis which are;
We continue to search for high THC varieties, as well as breed exclusive strains, to deliver personalised medicines customised for different diseases and symptoms.
We’re thrilled to announce we have received our export licence from the Drug Control Section of the ODC (Office of Drug Control). We’re firmly on course to continue to lead the way and be the first medicinal cannabis company in Australia to export cannabis flower to the EU since export was legalised in 2018.
One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.
In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.LEARN ABOUT ANTG HERE >